GENTLY RESTORE NORMAL HEART RHYTHM
We understand that an abnormally fast heart rhythm can have a life-altering impact on a patient and family. For those who are living with atrial fibrillation (AF), ventricular tachycardia (VT) or who have had or are at risk of ventricular fibrillation (VF), Cardialen’s MultiPulse™ Therapy (MPT) is an investigational therapy delivering low-energy pulse therapy to potentially restore a normal heart rhythm. Lower energy could minimize painful and potentially damaging side effects associated with current therapies.
HOW MULTIPULSE THERAPY WORKS
How MultiPulse Therapy can potentially detect and treat atrial fibrillation (AF), rapid ventricular tachycardia (VT) and ventricular fibrillation (VF).
Advancing cardioversion and defibrillation using low-energy therapy
Cardialen, Inc. is an early-stage medical device company dedicated to advancing implantable cardioversion and defibrillation using low energy for use as a first-line therapy to restore normal heart rhythm and may reduce the potential for high-energy defibrillation shocks.
Our MultiPulse™ Therapy (MPT) is currently being studied in an FDA-approved early feasibility IDE clinical trial exploring how a sequence of low-energy pulses timed to stop abnormal heart rhythms may restore normal heart rhythm using less energy than current high-energy shocks.
CAUTION: Investigational Device. Limited by Federal (United States) law to investigational use only
BOARD OF DIRECTORS
LEARN MORE ABOUT CLINICAL TRIALS
If you are a patient or physician interested in learning more about clinical trials, please contact us.
Interested in joining the Cardialen team?
Please complete the form.